Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV
Published August 3, 2022 · Recall initiated: July 5, 2022
Summary
FDA records drug Class I recall D-1292-2022, published August 3, 2022 and initiated July 5, 2022. Recalling firm: Mylan Pharmaceuticals Inc; Status: Terminated; Reported quantity: 253,200 pens (50,650/5 per packs); Lot: Lot #: BF21002895, Exp. Date Aug 2023. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Missing label: Label missing from some prefilled pens.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Pharmaceuticals Inc
- Distributor
- Product was distributed nationwide within the United States
- Lot
- Lot #: BF21002895, Exp. Date Aug 2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only,September 9, 2026
- FDAPrasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan PharmaceuticalsSeptember 9, 2026
- FDAAcamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan PharmaceuticalsAugust 26, 2026
- FDADivalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun PharmaceuticalAugust 3, 2022
- FDAIrbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee-August 3, 2022
- FDAInsulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-DoseMay 4, 2022
Questions about this recall
Was Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV recalled?
Yes. FDA published recall D-1292-2022 on August 3, 2022. Reported hazard: Labeling: Missing label: Label missing from some prefilled pens.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release